Bull
$494.79
Scenario price
$436.950
-7.079 (-1.62%)At close
Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments.
Waters Corp (WAT) is a good buy right now, as it is currently priced at $433.77, with a forward P/E ratio of 24.75, suggesting reasonable valuation compared to its growth potential. The stock has shown a strong year-to-date change of +13.56% and a one-year change of +28.97%, indicating solid performance. However, there is a risk with insider selling increasing by 125.80% over the last quarter, which could signal caution among insiders.
BofA
$465
2026-10-09
BofA
2026-10-09
Price Target
$465
Barclays
$500
2026-10-07
Barclays
2026-10-07
Price Target
$500
Guggenheim
$490
2026-10-01
Guggenheim
2026-10-01
Price Target
$490
Goldman Sachs
$515
2026-09-21
Goldman Sachs
2026-09-21
Price Target
$515
UBS
$490
2026-09-09
UBS
2026-09-09
Price Target
$490
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Waters Launches AI Link Software to Drive Laboratory Automation

Market Outlook: Tech Stock Dynamics and Investment Opportunities

Waters Launches BD FACSDiscover A7 Cell Analyzer for Enhanced Flow Cytometry

Waters CEO to Participate in J.P. Morgan Conference

Waters CEO to Participate in J.P. Morgan Conference
Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).
Waters Corp (WAT) is a good buy right now, as it is currently priced at $433.77, with a forward P/E ratio of 24.75, suggesting reasonable valuation compared to its growth potential. The stock has shown a strong year-to-date change of +13.56% and a one-year change of +28.97%, indicating solid performance. However, there is a risk with insider selling increasing by 125.80% over the last quarter, which could signal caution among insiders.
15 analysts cover WAT: 5 rate it Buy, 9 Hold and 1 Sell. The average price target is 414.08.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.